Clinical Trial Update: Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is comparing dabigatran to rivaroxaban for the treatment of cerebral venous sinus thrombosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Venous Sinus Thrombosis

Drugs mentioned

• Pradaxa (dabigatran etexilate)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Cerebral Venous Sinus Thrombosis | Phase 3 | Status: RECRUITING